Stockholder's Equity | Stockholders' Equity During the nine -month period ended September 24, 2017 , we repurchased 2,022,488 shares of our common stock at an aggregate purchase price of $312,249 . The repurchased shares were concurrently retired and credited to authorized but unissued stock as we are able to reissue these shares. The repurchase of these shares and other activity resulted in a decrease in common stock of $13,371 and a decrease in retained earnings of $298,878 . The shareholders of the Company approved the Company’s 2017 Incentive Compensation Plan (the “2017 Plan”) on June 2, 2017 (the “Approval Date”). So long as shares remain available, equity awards may be granted under this plan until June 2, 2027. The Company’s authority to grant new awards under the 2012 Equity Incentive Plan (the “2012 Plan”) terminated upon shareholder approval of the 2017 Plan on the Approval Date. The number of shares of our common stock that may be the subject of awards and issued under the 2017 Plan was initially 2,250,000 , less the number of shares granted under the 2012 Plan after December 25, 2016 and before the Approval Date. Shares subject to awards outstanding under the 2012 Plan or the 2003 Equity Incentive Plan, as amended, that expire, are forfeited, or settled in cash on or after December 26, 2016, will become available for grant under the 2017 Plan. The Plan had 1,923,596 shares available for grant as of September 24, 2017 . Stock Options The exercise price for stock options issued under the Plan is to be not less than the fair market value on the date of grant with respect to incentive and nonqualified stock options. Incentive stock options and nonqualified stock options vest in four annual installments at the end of each fiscal year following the date of grant and have a contractual life of seven years. We issue new shares of common stock upon the exercise of stock options. Option activity for the nine months ended September 24, 2017 is summarized as follows: Number of shares Weighted average exercise price Average remaining contractual life (years) Aggregate intrinsic value Outstanding, December 25, 2016 145,624 $ 129.89 4.1 $ 5,076 Granted 52,539 145.31 Exercised (24,513 ) 87.74 Cancelled (19,283 ) 157.24 Outstanding, September 24, 2017 154,367 $ 138.41 4.1 $ 766 Exercisable, September 24, 2017 71,465 $ 123.47 2.6 $ 766 The aggregate intrinsic value in the table above is before applicable income taxes, based on our closing stock price of $105.05 as of the last business day of the nine -month period ended September 24, 2017 , which would have been received by the optionees had all options been exercised and sold on that date. As of September 24, 2017 , total unrecognized stock-based compensation expense related to nonvested stock options was approximately $1,592 , which is expected to be recognized over a weighted average period of approximately 2.6 years . During the nine -month periods ended September 24, 2017 and September 25, 2016 , the total intrinsic value of stock options exercised was $1,078 and $848 , respectively. During the nine -month periods ended September 24, 2017 and September 25, 2016 , the weighted average grant date fair values of options were $45.73 and $47.67 , respectively. During the nine -month periods ended September 24, 2017 , the total fair value of options vested was $ 97 . No shares vested during the nine months ended September 25, 2016 . Restricted Stock Units Restricted stock units are granted annually under the Plan at the discretion of the Compensation Committee of our Board of Directors. We grant restricted stock units subject to service conditions (“time-based”) as well as units subject to both service and performance conditions (“performance-based”). Our time-based restricted stock units are generally granted subject to a two -year graded vesting schedule. Our performance-based restricted stock units are granted subject to a three -year cliff vesting and cumulative three -year financial targets. The number of performance-based restricted stock units that vest at the end of the three -year period is based on actual performance against the targets. These restricted stock units are subject to forfeiture if they have not vested at the end of the three -year period. Stock-based compensation is recognized for the number of units expected to vest at the end of the period and is expensed beginning on the grant date through the end of the performance period. For each performance-based grant, restricted stock units meeting the performance criteria will vest as of the end of the third fiscal year in the performance period, subject to a Plan-specified maximum number of shares that may be issued to any individual in any year in settlement of restricted stock units. The distribution of vested restricted stock units as common stock typically occurs in March of the following year. The common stock is issued to participants net of the number of shares required for employee withholding taxes, which can be withheld between the relevant jurisdiction's minimum and maximum statutory rates. We issue new shares of common stock upon the disbursement of restricted stock units. Restricted stock units are contingently issuable shares, and the activity for the nine months ended September 24, 2017 was as follows: Number of shares Weighted average grant date fair value Outstanding, December 25, 2016 202,047 $ 160.03 Granted 208,123 151.40 Vested (9,033 ) 131.67 Cancelled (61,549 ) 158.44 Outstanding, September 24, 2017 339,588 $ 155.79 As of September 24, 2017 , the total stock-based compensation expense related to nonvested awards not yet recognized was $8,826 , which is expected to be recognized over a weighted average period of 1.8 years. During the nine -month periods ended September 24, 2017 and September 25, 2016 , the total grant date fair value of shares vested was $1,189 and $912 , respectively. The weighted average grant date fair values of restricted stock units granted during the nine -month periods ended September 24, 2017 and September 25, 2016 were $151.40 and $147.02 , respectively. During the nine -month periods ended September 24, 2017 and September 25, 2016 , we recognized $3,831 and $862 , respectively, of stock-based compensation expense related to restricted stock units. Employee Stock Purchase Plan We have reserved 600,000 shares of common stock for issuance under our Employee Stock Purchase Plan (ESPP). The ESPP is available to substantially all employees subject to employment eligibility requirements. Participants may purchase our common stock at 85% of the beginning or ending closing price, whichever is lower, for each six-month period ending in May and November. During the nine -month periods ended September 24, 2017 and September 25, 2016 , we issued 9,942 and 12,857 shares of common stock, respectively, under the ESPP. As of September 24, 2017 , we had 151,197 shares available for future issuance under the ESPP. |